38th ENA (EORTC-NCI-AACR) Symposium on Molecular Targets and Cancer Therapeutics

Recognised as a leading forum for drug development and translational research, ENA 2026 will spotlight cutting-edge preclinical and phase I studies, fostering deep scientific exchange around emerging targets and novel therapeutics. Bringing together a global community of researchers, clinicians, and industry experts, the Symposium offers a dynamic platform to explore the latest breakthroughs in molecular biology, target identification, and drug innovation.